4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-082116
Options or other derivatives
- VP, Research & Development acquired 129,771 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Hayon Yael VP, Research & Development | 2020-07-05 | Grant or award · Stock Options (Right to Buy) | +129,771 | 129,771 | D | ||
Loading xslF345X03/tm2024387d2_4.xml…